opc 14117 has been researched along with Cognition Disorders in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aoyama, N; Katayama, Y; Kawamata, T; Kikuchi, T; Maeda, T; Mori, T; Uwahodo, Y; Yamamoto, T | 1 |
1 trial(s) available for opc 14117 and Cognition Disorders
Article | Year |
---|---|
Vitamin E drug.
Topics: AIDS Dementia Complex; Antioxidants; Cognition Disorders; Free Radical Scavengers; HIV Infections; Humans; Indans; Piperazines; Placebos; Randomized Controlled Trials as Topic; Vitamin E | 1995 |
1 other study(ies) available for opc 14117 and Cognition Disorders
Article | Year |
---|---|
Effects of antioxidant, OPC-14117, on secondary cellular damage and behavioral deficits following cortical contusion in the rat.
Topics: Animals; Antioxidants; Behavior, Animal; Body Temperature; Brain Edema; Brain Injuries; Cell Death; Cerebral Cortex; Cognition Disorders; Hippocampus; Indans; Male; Maze Learning; Necrosis; Nerve Degeneration; Osmolar Concentration; Oxidative Stress; Piperazines; Rats; Rats, Wistar; Specific Gravity; Time Factors | 2002 |